Article

CMS to Phase in Controversial Payment Cut to Dialysis Providers

In what is likely to be a relief to dialysis providers, the CMS decided to phase in the controversial payment cut to dialysis providers over a three- to four-year period.

In what is likely to be a relief to dialysis providers, the CMS decided to phase in the controversial payment cut to dialysis providers over a three- to four-year period.

Moreover, overall payments for 2014 will remain the same, according to the final rule issued Friday (PDF).

A tax bill passed in January calls for the rebasing of dialysis rates to better reflect decreased utilization of expensive anemia drugs that have been linked to safety concerns. But the industry has lobbied heavily against the cut, arguing that the drugs themselves have become more expensive and more drugs are being added to the bundled payment.

The final rule also authorized a 50% increase to the home dialysis training add-on payment and strengthened the Quality Incentive Program, which penalizes providers who don't meet certain performance standards.

Read the full story here: http://bit.ly/19W8WIi

Source: Modern Healthcare

Related Videos
Ali Khawar
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Related Content
CH LogoCenter for Biosimilars Logo